Cargando…
EMILIN2 is associated with prognosis and immunotherapy in clear cell renal cell carcinoma
Background: EMILIN2 is a platelet-associated elastin that regulates angiogenesis. It has recently been found to play an essential role in various tumors. Nevertheless, the mechanism of action of EMILIN2 in clear cell renal cell carcinoma (ccRCC) remains unclear. Methods: Samples from 33 cancers were...
Autores principales: | Zhao, Guangjian, Zheng, Jianpei, Tang, Kai, Chen, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760906/ https://www.ncbi.nlm.nih.gov/pubmed/36544490 http://dx.doi.org/10.3389/fgene.2022.1058207 |
Ejemplares similares
-
A DNA Damage Repair Gene Signature Associated With Immunotherapy Response and Clinical Prognosis in Clear Cell Renal Cell Carcinoma
por: Peng, Linjie, et al.
Publicado: (2022) -
The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
por: Zhang, Lishuo, et al.
Publicado: (2023) -
Sarcomatoid-associated gene risk index for clear cell renal cell carcinoma
por: Zuo, You, et al.
Publicado: (2022) -
Expression of AOX1 Predicts Prognosis of Clear Cell Renal Cell Carcinoma
por: Xiong, Luyang, et al.
Publicado: (2021) -
An Aging and Senescence-Related Gene Signature for Prognosis Prediction in Clear Cell Renal Cell Carcinoma
por: Li, Jiaying, et al.
Publicado: (2022)